Scroll to view more GLP-1R activation in the pancreas enhances the secretion of insulin when elevated levels of blood glucose are present, and when coupled with GIPR activation in the pancreas, which stimulates beta cells to ramp up insulin production, blood sugar can be more effectively regulated in the treatment of Type 2 diabetes
These representative cases go to trial to test the waters on outcomes, which can influence settlement discussions for the remaining cases
Its long-acting effect is achieved through the following structural innovations: Amino acid modification: The alanine at position 8 is replaced with -aminoisobutyric acid (Aib), which helps the molecule resist degradation by dipeptidyl peptidase-4 (DPP-4)
Calculations like the one in this paper may prove even more important as employers grapple with the effect of GLP-1s on their healthcare budgets
Goodson AG, Florell SR, Hyde M, Bowen GM, Grossman D
Approval in 2017